Eloralintide
N/A
Report date: 2026/05/18 20:02:07
Base Information
Drug NameEloralintide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[24]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesIncog Biopharma Services IncEli Lilly (Beijing) Medical Technology Innovation Co., Ltd.Eli Lilly And Company
Inactive CompaniesN/A
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG